Biocryst Pharmaceuticals (BCRX) Selling, General & Administrative (2010 - 2026)
Powered by 
Analysis
Biocryst Pharmaceuticals (BCRX) Selling, General & Administrative (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.05 Bn | 197.06 Bn | 7.24 Bn | 1.75 Bn |
| 2 | Gilead Sciences | 181.07 Bn | 177.90 Bn | 6.22 Bn | 1.92 Bn |
| 3 | Vertex Pharmaceuticals | 132.15 Bn | 124.30 Bn | 2.84 Bn | 582.20 Mn |
| 4 | Regeneron Pharmaceuticals | 82.66 Bn | 74.67 Bn | 3.93 Bn | 662.10 Mn |
| 5 | Argenx Se | 61.74 Bn | 56.55 Bn | 1.37 Bn | -417.00 Mn |
| 6 | Moderna | 54.51 Bn | 49.37 Bn | 52.00 Mn | 216.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.05 Bn | 30.74 Bn | 992.69 Mn | 347.92 Mn |
| 8 | Biogen | 31.25 Bn | 29.97 Bn | 1.96 Bn | 709.70 Mn |
| 9 | Roivant Sciences | 29.88 Bn | 29.88 Bn | 1.16 Mn | 165.53 Mn |
| 10 | Biocryst Pharmaceuticals | 2.33 Bn | 1.97 Bn | 214.41 Mn | 63.98 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 63.98 Mn |
| Mar 31, 2026 | 94.55 Mn |
| Dec 31, 2025 | 95.78 Mn |
| Sep 30, 2025 | 83.01 Mn |
| Jun 30, 2025 | 87.38 Mn |
| Mar 31, 2025 | 82.47 Mn |
| Dec 31, 2024 | 80.51 Mn |
| Sep 30, 2024 | 65.10 Mn |
| Jun 30, 2024 | 61.25 Mn |
| Mar 31, 2024 | 59.49 Mn |
| Dec 31, 2023 | 64.56 Mn |
| Sep 30, 2023 | 50.65 Mn |
| Jun 30, 2023 | 51.00 Mn |
| Mar 31, 2023 | 47.87 Mn |
| Dec 31, 2022 | 50.15 Mn |
| Sep 30, 2022 | 36.92 Mn |
| Jun 30, 2022 | 38.02 Mn |
| Mar 31, 2022 | 34.28 Mn |
| Dec 31, 2021 | 35.39 Mn |
| Sep 30, 2021 | 34.99 Mn |